| 000 | 01373 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513132757.0 | ||
| 264 | 0 | _c19980115 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a1420-682X | ||
| 024 | 7 |
_a10.1007/s000180050101 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVallee, B L | |
| 245 | 0 | 0 |
_aOrganogenesis and angiogenin. _h[electronic resource] |
| 260 |
_bCellular and molecular life sciences : CMLS _cOct 1997 |
||
| 300 |
_a803-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inducing Agents _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xtherapy |
| 650 | 0 | 4 | _aNeovascularization, Physiologic |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aProteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xmetabolism |
| 650 | 0 | 4 |
_aRibonuclease, Pancreatic _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aRiordan, J F | |
| 773 | 0 |
_tCellular and molecular life sciences : CMLS _gvol. 53 _gno. 10 _gp. 803-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s000180050101 _zAvailable from publisher's website |
| 999 |
_c9383129 _d9383129 |
||